Evidence map›Paper›PMID 36246909›Full record

ArticleFrontiers in endocrinology2022

Guillermo Galdon, Nicholas A Deebel, Nima Pourhabibi Zarandi, Darren Teramoto, YanHe Lue, Christina Wang, Ronald Swerdloff, Mark J Pettenati, William G Kearns, Stuart Howards and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Induction of Meiosis from Human Pluripotent Stem Cells.bioRxiv : the preprint server for biology · 2024
    Article
  6. Isolation and In Vitro Propagation of Human Spermatogonial Stem Cells (SSCs).Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Guillermo GaldonWake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, NC, United States.
Nicholas A DeebelWake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, NC, United States.
Nima Pourhabibi ZarandiWake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, NC, United States.
Darren TeramotoDivision of Endocrinology, The Lundquist Institute at Harbor-University of California, Los Angeles (UCLA) Medical Center, Los Angeles, CA, United States.
YanHe LueDivision of Endocrinology, The Lundquist Institute at Harbor-University of California, Los Angeles (UCLA) Medical Center, Los Angeles, CA, United States.
Christina WangDivision of Endocrinology, The Lundquist Institute at Harbor-University of California, Los Angeles (UCLA) Medical Center, Los Angeles, CA, United States.
Ronald SwerdloffDivision of Endocrinology, The Lundquist Institute at Harbor-University of California, Los Angeles (UCLA) Medical Center, Los Angeles, CA, United States.
Mark J PettenatiSection of Medical Genetics, Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
William G KearnsAdvaGenix and Johns Hopkins Medicine, Baltimore and Rockville, MD, United States.
Stuart HowardsDepartment of Urology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Stanley KoganWake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, NC, United States.
Anthony AtalaWake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, NC, United States.
Hooman Sadri-ArdekaniWake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, NC, United States.
Wake Forest University · USForest Institute · USUCLA Medical Center · USUniversity of California, Los Angeles · USJohns Hopkins University · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
NCATS NIH HHS UL1 TR001881
6 · The paper itself

Abstract

Klinefelter Syndrome (KS) is characterized by a masculine phenotype, supernumerary sex chromosomes (47, XXY), and impaired fertility due to loss of spermatogonial stem cells (SSCs). Early testicular cryopreservation could be an option for future fertility treatments in these patients, including SSCs transplantation or

Indexed as

Klinefelter SyndromeSpermatogoniaAdolescentHumansIntegrin alpha6MaleSpermatogenesisStem CellsTestisIntegrin alpha6cell culturefertility preservationgerm cell transplantationKlinefelter Syndromemale infertilityspermatogoniastem cell

Identifiers

PMID36246909
PMCPMC9554955
OpenAlexW4297492897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.